NCT04319653

Brief Summary

The conditions such as childbirth or endometriosis can lead to a change in the mobility of the pelvic organs (bladder, vagina, rectum and uterus). The purpose of the study is to study in a personalized way each woman the characteristics of the tissues of their pelvis and to be able to personalize the treatments (surgery, injection, rehabilitation, etc.). Women requiring pelvic MRI may participate in the study. The pelvic dynamic MRI will be done with an intravaginal probe which will be inserted by the patient herself as well as gel in the anus and vagina which will allow to obtain the data on the characteristics of the pelvic tissues of each woman with a 3D reconstruction.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 24, 2020

Completed
1.1 years until next milestone

Study Start

First participant enrolled

April 13, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 13, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 13, 2021

Completed
Last Updated

December 11, 2025

Status Verified

December 1, 2025

Enrollment Period

1 month

First QC Date

March 20, 2020

Last Update Submit

December 4, 2025

Conditions

Keywords

Geometrical reconstructionPelvic Floor DisordersFE modelsPelvic systemMRI

Outcome Measures

Primary Outcomes (1)

  • 3D reconstruction of the pelvic cavity

    Characterization of the pelvic cavity through a double assessment: a pelvic MRI sequence and an intravaginal pressure probe.

    at 1 month

Study Arms (1)

Dynamic pelvic MRI

EXPERIMENTAL
Device: Dynamic pelvic MRI with intravaginal probe with pressure sensor

Interventions

Dynamic pelvic MRI with intravaginal probe and intravaginal and intrarectal opacification gel

Dynamic pelvic MRI

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThe recruitment of patients will be done during a consultation within the Obstetric Gynecology Department CHU of Lille to select those requiring a pelvic MRI.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All:
  • Understanding of the French language
  • Signature of informed consent
  • Insured social patient
  • For pregnant women:
  • Primiparous women
  • with no severe maternal-fetal pathology
  • with no scheduled caesarean section at the time of the MRI
  • For women with prolapse:
  • \- Requires pelvic MRI

You may not qualify if:

  • Minor
  • Person who does not have social security
  • Person with ongoing vaginal infection
  • Pregnant woman during the first or third trimester of pregnancy
  • Pregnant woman with broken water pocket
  • Bi-cicatricial uterus
  • IVF
  • Person wearing a pace maker or any intra-body metal implant (if "tube" MRI)
  • Claustrophobic person (if "tube" MRI)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Jeanne de Flandres, CHU

Lille, France

Location

MeSH Terms

Conditions

Pelvic Floor Disorders

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Study Officials

  • Michel COSSON, MD,PhD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 20, 2020

First Posted

March 24, 2020

Study Start

April 13, 2021

Primary Completion

May 13, 2021

Study Completion

May 13, 2021

Last Updated

December 11, 2025

Record last verified: 2025-12

Locations